IRIS
LEVANDIS, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 496
EU - Europa 252
AS - Asia 37
AF - Africa 4
OC - Oceania 1
SA - Sud America 1
Totale 791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 493
IE - Irlanda 168
CN - Cina 34
FI - Finlandia 29
DE - Germania 22
IT - Italia 13
BE - Belgio 6
UA - Ucraina 5
FR - Francia 4
CA - Canada 3
MU - Mauritius 3
IN - India 2
SE - Svezia 2
AU - Australia 1
BR - Brasile 1
GB - Regno Unito 1
HK - Hong Kong 1
LU - Lussemburgo 1
NL - Olanda 1
ZA - Sudafrica 1
Totale 791
Salva come PNG Salva come JPEG
Città #
Chandler 171
Dublin 168
Ashburn 79
Helsinki 25
Princeton 24
Lawrence 23
Medford 22
Wilmington 15
Washington 11
Shanghai 10
Beijing 8
Jacksonville 7
Pavia 7
Brussels 6
New York 6
Norwalk 5
Giessen 4
Shenyang 4
Los Angeles 3
Rome 3
Ann Arbor 2
Berlin 2
Hebei 2
Jiaxing 2
Nanchang 2
Nanjing 2
Ostiglia 2
Tianjin 2
Toronto 2
Wuhan 2
Almere Stad 1
Andover 1
Boardman 1
Centurion 1
Dearborn 1
Fairfield 1
Falkenstein 1
Hyderabad 1
Luxembourg 1
Montreal 1
Redmond 1
Redwood City 1
Sydney 1
São Paulo 1
Totale 635
Salva come PNG Salva come JPEG
Nome #
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model 85
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease 51
Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: Potential relevance to the pathophysiology of Parkinson's disease 44
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 42
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease 39
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 38
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells 38
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 37
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease 36
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease 35
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects 35
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease 35
Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine 34
Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease 33
Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease 32
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 31
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease 29
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease 29
Influence of estrogen modulation on glia activation in a murine model of parkinson's disease 27
Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease 24
Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease 24
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: New clues from an old model 24
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat 13
Totale 815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 7 6 0 1 0 3 0 2 0 5 10 0
2020/202136 1 3 0 1 0 1 1 4 21 1 1 2
2021/2022107 0 0 1 1 0 0 2 4 10 1 12 76
2022/2023452 57 41 7 36 30 35 0 31 203 0 7 5
2023/2024169 22 24 12 9 22 64 5 4 1 6 0 0
Totale 815